Tyco Healthcare Group LP v. Ethicon Endo-Surgery, Inc., No. 13-1324 (Fed. Cir. Dec. 4, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Ethicon Endo -Surgery, Inc. appeals from a U.S. District Court for t he District of Connecticut judgment that certain asserted claims of Tyco Healthcare Group LP’s U.S. Patent Nos. 6,68 2,544 (“’544 patent”), 6,063,050 (“’050 patent”) , and 6,468,286 (“’286 patent”) would not have been obvious under 35 U.S.C. § 103. Tyco cross - appeals from the district court’s conclusion that the other asserted claims are anticipated under 35 U.S.C. § 102(g).